Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Biochemical and Biophysical Research Communications
|
June 7, 2005
Modulation of cholinephosphotransferase activity in breast cancer cell lines by Ro5-4864, a peripheral benzodiazepine receptor agonist
Jacqueline Akech, Somdutta Sinha Roy, Salil K Das
Biochemical and Biophysical Research Communications
|
October 3, 2002
Differential expression of cholinephosphotransferase in normal and cancerous human mammary epithelial cells
Aparajita Ghosh, Jacqueline Akech, Shyamali Mukherjee, et al.
International Journal of Cancer
|
July 24, 2014
Runx2-Smad signaling impacts the progression of tumor-induced bone disease
Xuhui Zhang, Jacqueline Akech, Gillian Browne, et al.
Journal of Cellular Biochemistry
|
March 27, 2015
Expression of the IL-11 Gene in Metastatic Cells Is Supported by Runx2-Smad and Runx2-cJun Complexes Induced by TGFβ1
Xuhui Zhang, Hai Wu, Jason R Dobson, et al.
Cancer Research
|
January 31, 2015
Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease
Hanna Taipaleenmäki, Gillian Browne, Jacqueline Akech, et al.
Journal of Cellular Biochemistry
|
January 19, 2010
The cancer-related Runx2 protein enhances cell growth and responses to androgen and TGFbeta in prostate cancer cells
Margaretha van der Deen, Jacqueline Akech, Tao Wang, et al.
The Journal of Biological Chemistry
|
December 14, 2011
Genomic promoter occupancy of runt-related transcription factor RUNX2 in Osteosarcoma cells identifies genes involved in cell adhesion and motility
Margaretha van der Deen, Jacqueline Akech, David Lapointe, et al.
Cancer Research
|
August 20, 2009
Ectopic runx2 expression in mammary epithelial cells disrupts formation of normal acini structure: implications for breast cancer progression
Jitesh Pratap, Karen M Imbalzano, Jean M Underwood, et al.
Molecular Cancer Therapeutics
|
December 17, 2010
The histone deacetylase inhibitor, vorinostat, reduces tumor growth at the metastatic bone site and associated osteolysis, but promotes normal bone loss
Jitesh Pratap, Jacqueline Akech, John J Wixted, et al.
Cancer Research
|
January 4, 2014
Integrin αvβ6 promotes an osteolytic program in cancer cells by upregulating MMP2
Anindita Dutta, Jing Li, Huimin Lu, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Biochemical and Biophysical Research Communications
|
June 7, 2005
Modulation of cholinephosphotransferase activity in breast cancer cell lines by Ro5-4864, a peripheral benzodiazepine receptor agonist
Jacqueline Akech, Somdutta Sinha Roy, Salil K Das
Biochemical and Biophysical Research Communications
|
October 3, 2002
Differential expression of cholinephosphotransferase in normal and cancerous human mammary epithelial cells
Aparajita Ghosh, Jacqueline Akech, Shyamali Mukherjee, et al.
International Journal of Cancer
|
July 24, 2014
Runx2-Smad signaling impacts the progression of tumor-induced bone disease
Xuhui Zhang, Jacqueline Akech, Gillian Browne, et al.
Journal of Cellular Biochemistry
|
March 27, 2015
Expression of the IL-11 Gene in Metastatic Cells Is Supported by Runx2-Smad and Runx2-cJun Complexes Induced by TGFβ1
Xuhui Zhang, Hai Wu, Jason R Dobson, et al.
Cancer Research
|
January 31, 2015
Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease
Hanna Taipaleenmäki, Gillian Browne, Jacqueline Akech, et al.
Journal of Cellular Biochemistry
|
January 19, 2010
The cancer-related Runx2 protein enhances cell growth and responses to androgen and TGFbeta in prostate cancer cells
Margaretha van der Deen, Jacqueline Akech, Tao Wang, et al.
The Journal of Biological Chemistry
|
December 14, 2011
Genomic promoter occupancy of runt-related transcription factor RUNX2 in Osteosarcoma cells identifies genes involved in cell adhesion and motility
Margaretha van der Deen, Jacqueline Akech, David Lapointe, et al.
Cancer Research
|
August 20, 2009
Ectopic runx2 expression in mammary epithelial cells disrupts formation of normal acini structure: implications for breast cancer progression
Jitesh Pratap, Karen M Imbalzano, Jean M Underwood, et al.
Molecular Cancer Therapeutics
|
December 17, 2010
The histone deacetylase inhibitor, vorinostat, reduces tumor growth at the metastatic bone site and associated osteolysis, but promotes normal bone loss
Jitesh Pratap, Jacqueline Akech, John J Wixted, et al.
Cancer Research
|
January 4, 2014
Integrin αvβ6 promotes an osteolytic program in cancer cells by upregulating MMP2
Anindita Dutta, Jing Li, Huimin Lu, et al.
Page
of 2